Acute cardiac care & resuscitationCohort study
Timing of Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients with Cardiogenic Shock
- Multicentre cohort study
- 15 tertiary care centres in three countries
- exploratory
Authors' conclusion
In this exploratory study of patients with CS treated with MCS, the timing of device implantation within 24 h after CS onset was not associated with mortality.
Study context
- Population
- Patients with cardiogenic shock (CS) treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and/or microaxial flow pump
- Participants
- 330 patients
- Exposure
- Early vs intermediate vs delayed mechanical circulatory support (MCS) implantation after CS onset
- Outcome
- 30-day all-cause mortality
- Follow-up
- 30 days
Main finding
As reported in the abstract
Observational data: associations, not effects.
Further findings
Group shares
Safety
Complications, related and unrelated to MCS
- Did not differ significantly among groups
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Timing of Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients with Cardiogenic Shock. Eur J Heart Fail. Published 24 October 2024. doi:10.1002/ejhf.3498
Summarised from the published abstract; every number is checked against it